Your browser doesn't support javascript.
loading
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer.
Nicholson, Hugh A; Sawers, Lynne; Clarke, Rosemary G; Hiom, Kevin J; Ferguson, Michelle J; Smith, Gillian.
Afiliação
  • Nicholson HA; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
  • Sawers L; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
  • Clarke RG; Centre for Advanced Scientific Technologies, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.
  • Hiom KJ; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
  • Ferguson MJ; Tayside Cancer Centre, NHS Tayside, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
  • Smith G; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. g.smith@dundee.ac.uk.
Br J Cancer ; 127(7): 1340-1351, 2022 10.
Article em En | MEDLINE | ID: mdl-35778553

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article